Vector Potency Assay Development & Implementation to Enhance Autologous Cell Therapy Manufacturing Success

Time: 1:35 pm
day: Pre-Conference Day - Analytical Dev Track PM

Details:

  • Highlighting the increased regulatory expectation and the importance of robust viral vector quality control strategy to enhance cell therapy manufacturing success
  • Potency assay for viral vector vs autologous cell therapy final product
  • Discuss common challenges and present case studies on the development of fit-for purpose vector potency assays

Speakers: